SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
CID Holdco entered into a Note Purchase Agreement on June 23, 2026, creating a new $500,000 Senior Secured Convertible Promissory Note with Phillips Equities & Trust, LLC, bearing 6% interest, 12-month maturity, convertibility into common stock, and secured by substantially all company assets.
View raw filing on EDGAR →CID Holdco retired in full approximately $867,000 principal of White Lion Senior Secured Convertible Promissory Notes through conversion and released all associated liens and security interests, simplifying the company's capital structure and eliminating secured debt obligations.
View raw filing on EDGAR →CID Holdco issued a $500,000 secured convertible note to a new investor in reliance on Section 4(a)(2) and Regulation D exemptions, providing additional capital through an unregistered private placement of a dilutive equity instrument.
View raw filing on EDGAR →CID Holdco disclosed ongoing Nasdaq continued listing compliance deficiencies regarding minimum market value of listed securities ($50 million) and minimum market value of publicly held shares ($15 million), despite regaining compliance with the Bid Price Requirement as of June 23, 2026.
View raw filing on EDGAR →Brenmiller Energy announced the purchase of a 1.2 MWp photovoltaic facility in Hungary for approximately $1.1 million. This is a material acquisition of a revenue-generating asset that marks a strategic shift in the company's business model—from a thermal energy storage equipment provider toward an owner and operator of clean energy infrastructure. The press release explicitly states this purchase "marks an important step in Brenmiller's evolution" and is "the first execution of Brenmiller Energy's BNRG360 strategy," indicating this is a significant strategic transaction that would affect a reasonable investor's assessment of the company's direction and asset base.
View raw filing on EDGAR →The filing discloses a significant business development: Virtuix's first Air National Guard deployment of its Omni One platform, along with a series of recent defense sector wins (Air Force SBIR award, Marine Corps lead integrator role, Navy development agreement, Army/Air Force deployments). The company also announces it is "actively reviewing several acquisition opportunities in the defense training and simulation sector" targeting companies with $10–50M in annual revenue. This is a material operational and strategic milestone expanding the company's defense market presence, though it does not fit the specific categories of M&A activity (no acquisition completed), earnings release, or other named event types. The disclosure would affect a reasonable investor's assessment of the company's growth trajectory and market positioning.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder voting results from the Annual Meeting of Stockholders held on July 1, 2026. The filing reports the final voting tallies for two proposals: (1) election of Class I directors Glenn Duffy and William Gates, and (2) ratification of Grant Thornton LLP as independent auditor. The disclosure of director elections and auditor ratification results is material to investors' understanding of corporate governance and board composition.
View raw filing on EDGAR →The 6-K reports the results of Turbo Energy's Annual General Shareholders' Meeting held on June 29, 2026, disclosing voting outcomes on eight proposals including election of eight board directors (Proposal 1, approved 99.50%), ratification of auditors (Proposals 2 and 3), approval of annual accounts and management (Proposals 4–6), and procedural matters (Proposals 7–8). This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, material because board elections and auditor ratifications affect governance and investor assessment.
View raw filing on EDGAR →This press release announces successful completion of biocompatibility testing for NASARIX, a development-stage medical device product. The disclosure describes achievement of a pre-clinical regulatory milestone—passing all required biological safety assessments under ISO 10993 standards—that supports advancement toward first-in-human clinical trials. While this is a material operational/development milestone for a biotech company, it does not fit the specific event categories (earnings, M&A, executive changes, impairment, etc.); it is a product development achievement that materially advances the company's clinical and regulatory pathway.
View raw filing on EDGAR →The filing discloses the dismissal of Simon & Edward, LLP as the independent registered public accounting firm and engagement of Kreit & Chiu CPA LLP as the new auditor, effective June 30, 2026. This is a direct auditor change under Item 4.01. While the prior auditor's reports were unqualified except for a going-concern explanatory paragraph and there were no disagreements, the change itself is material to investors as it affects the registrant's financial reporting oversight and audit continuity.
View raw filing on EDGAR →Tenon Medical completed a registered public offering on July 1, 2026, issuing 11,052,631 shares of common stock (or pre-funded warrants) and 13,263,159 common stock purchase warrants, raising $4.2 million in gross proceeds. The offering includes warrants exercisable at $0.38 and $0.001 per share, with proceeds to be used in part for repayment of convertible notes, reflecting significant dilution to existing shareholders.
View raw filing on EDGAR →ISQ Open Infrastructure Co LLC completed unregistered sales of equity securities totaling $31.9 million across Series I and Series II share classes as of June 1, 2026, exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S.
View raw filing on EDGAR →The company acquired two equity investments in Mercury Data Center Holdings Limited and Cube Safety HoldCo Limited in June 2026, representing material portfolio expansion into data center and traffic safety infrastructure sectors.
View raw filing on EDGAR →This disclosure reports the consummation of Alpex Acquisition Corporation's initial public offering on June 26, 2026, raising $115 million in gross proceeds from the sale of 11.5 million units (including full exercise of the underwriter's over-allotment option) at $10.00 per unit, plus a concurrent private placement of 187,500 units to the sponsor for $1.875 million. While IPO completion is a material capital-raising event affecting the registrant's financial position and ability to pursue a business combination, it does not fit neatly into the standard 8-K taxonomy categories (which typically cover earnings releases, M&A activity, debt issuance, or other specific financial/operational events). The event is clearly material to investors but is best classified as a capital formation milestone that does not match a named category.
View raw filing on EDGAR →The Company sold 76.35 million shares of Common Stock over two days (June 30 and July 1, 2026) pursuant to an at-the-market (ATM) sales agreement with A.G.P./Alliance Global Partners, raising approximately $7.11 million in gross proceeds. This represents a dilutive issuance that increased outstanding shares from 21.5 million to 97.9 million—a 355% increase—which is material to investors' assessment of ownership dilution and capital structure.
View raw filing on EDGAR →This press release announces the results of WISeKey's 2026 Annual General Meeting held on June 29, 2026, disclosing that shareholders approved all agenda items including re-election of directors, election of a new director (Andrew Forson), re-election of the Chairman (Carlos Moreira), approval of the 2025 Annual Report, and all compensation-related proposals. This is a direct disclosure of shareholder vote results, matching Item 5.07 of the 8-K taxonomy and the `shareholder_vote_results` event type.
View raw filing on EDGAR →HeartBeam received a deficiency notice from Nasdaq on June 30, 2026, for failure to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The Company has been given a 180-day compliance period (until December 28, 2026) to regain compliance, with the explicit warning that failure to do so will result in delisting notice. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →MDxHealth received a Nasdaq notification dated June 30, 2026, that it has failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days (until December 28, 2026) to regain compliance or faces potential delisting. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting investor assessment of the company's continued listing status.
View raw filing on EDGAR →Bank of Chile placed senior dematerialized bearer bonds (Serie GA) in the local Chilean market on July 2, 2026, for CLF 250,000 with a maturity date of May 1, 2034, at an average placement rate of 3.03%. This is a creation of a new direct financial obligation and is explicitly filed as "Material Information" with the Chilean Financial Market Commission, meeting the definition of debt_issuance.
View raw filing on EDGAR →The 6-K discloses an amendment to a share purchase agreement for the acquisition of a 51% interest in RENTBUDDYUK LIMITED, with the transaction closing on June 29, 2026. The amendment restructures the acquisition mechanism (newly issued shares rather than existing share purchase) but maintains the material economic terms of US$5,326,840 total consideration. This constitutes a material acquisition activity requiring disclosure under Item 1.01 or 2.01 of the 8-K framework.
View raw filing on EDGAR →The company amended the Executive Employment Agreement of CEO Eric Gripentrog, replacing a $500,000 performance equity award with a grant of 3,500,000 fully vested stock options at $0.0055 per share. The amendment was approved by the Compensation Committee on June 30, 2026.
View raw filing on EDGAR →Columbus Circle Capital Corp II (Inflection Point), a SPAC, entered into a Business Combination Agreement dated June 26, 2026, with Elroy Air, Inc., whereby Inflection Point's merger subsidiary will merge with Elroy Air with Elroy Air as the surviving corporation. The transaction involves an $800 million purchase price, conversion of Elroy Air securities, and a $66.6 million pre-funded convertible note investment.
View raw filing on EDGAR →Elroy Air issued unregistered convertible promissory notes and warrants to institutional investors in a pre-funded offering under Section 4(a)(2) of the Securities Act as part of the business combination transaction.
View raw filing on EDGAR →Michael Blitzer was appointed as director and Chairman of the Board, and Kevin Shannon was appointed as Chief Executive Officer, both effective June 26, 2026, in connection with the Business Combination Agreement with Inflection Point Asset Management LLC.
View raw filing on EDGAR →OS Therapies entered into a securities purchase agreement on June 30, 2026, to issue a $10 million senior secured convertible promissory note, 275,000 commitment shares, and a five-year warrant for 1,750,000 shares to Leonite Fund I, LP in a private placement. The transaction includes anti-dilution provisions and beneficial ownership limitations tied to NYSE American stockholder-approval thresholds, with the company obligated to seek stockholder approval within 90 days.
View raw filing on EDGAR →OS Therapies established a $10 million line of credit supported by its UK subsidiary's tax credits, with an initial draw of $1.6 million, creating a new direct financial obligation.
View raw filing on EDGAR →Dr. Craig Eagle was appointed to OS Therapies' Board of Directors effective June 1, 2026, transitioning from Chief Medical Advisor. Dr. Eagle brings substantial oncology and pharmaceutical leadership experience, including prior roles as CMO at Guardant Health, VP Medical Affairs at Genentech, and senior positions at Pfizer.
View raw filing on EDGAR →The Compensation Committee approved a waiver to Section 3.2 of Bryant Riley's Employment Agreement, releasing holdback amounts attributable to Q1 and Q2 2026 that would otherwise have been withheld until Q1 2027. This is a modification of compensatory arrangements for a named executive officer, directly affecting the timing and amount of compensation payments. The waiver is material as it represents a material change to the executive's compensation structure based on performance.
View raw filing on EDGAR →The Company issued 2,400,000 Class B ordinary shares to the CEO/Chairman's affiliate (Lianyue Holding Limited) at $0.165 per share for gross proceeds of $396,000 under Regulation S. This is an unregistered equity issuance that is dilutive to existing shareholders; post-closing, the CEO's affiliate controls approximately 97.69% of aggregate voting power, representing a material concentration of control and significant dilution to public shareholders.
View raw filing on EDGAR →The filing discloses two material events: (1) completion of the Mortgage One Group acquisition (Item 2.01, ma_activity), and (2) a Nasdaq delisting notice due to failure to maintain the $1.00 minimum bid price for 30 consecutive business days (Item 3.01, delisting_risk). While both are material, the delisting notice is the more urgent and existential threat to the registrant. The company has 180 days to regain compliance or faces delisting, with explicit language that "there can be no assurance that the Company will be able to regain or maintain compliance." This is a terminal listing risk that would materially affect investor assessment.
View raw filing on EDGAR →The filing discloses the dismissal of PwC (Kesselman & Kesselman) as the Company's independent registered public accounting firm effective July 1, 2026, and the simultaneous engagement of Barzily & Co. as the new auditor. This is a classic auditor change under Item 4.01. The materiality is heightened by the fact that PwC's prior audit reports included an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern, signaling underlying financial stress that makes the auditor transition material to investors.
View raw filing on EDGAR →Jason Moos resigned from his position as Chief Financial Officer effective June 30, 2026, making this a departure of a named executive officer. While the disclosure also includes compensatory arrangements (retention payment and consulting fees), the principal disclosed action is the CFO's resignation. The departure of a CFO is material to investors assessing the registrant's financial leadership and operational continuity.
View raw filing on EDGAR →Peraso entered into a Common Stock Purchase Agreement with Roth Principal Investments establishing a committed equity facility (CEF) allowing the Company to sell up to $25 million of newly issued common stock at its discretion over 36 months, subject to Nasdaq rule limitations capping issuance at 19.99% of outstanding shares unless stockholder approval or a price threshold is met.
View raw filing on EDGAR →SoundHound AI entered into an Amended and Restated Merger Agreement on July 2, 2026, to acquire LivePerson, Inc. through a two-step merger structure. The filing discloses detailed consideration terms (stock and cash components), closing conditions, and representations and warranties typical of a material acquisition. This is a change-of-control transaction materially affecting the registrant's future and would significantly impact a reasonable investor's assessment of the company.
View raw filing on EDGAR →The Company entered into a securities purchase agreement to issue 400 shares of Series F Convertible Preferred Stock (convertible at $0.50/share) and 200,000 commitment shares of common stock for $400,000 in an unregistered private placement relying on Section 4(a)(2) and Rule 506(b), representing significant dilution to existing shareholders.
View raw filing on EDGAR →The Company issued approximately 1.5 million shares of unregistered equity securities in late June and early July 2026, including 150,000 restricted shares to a consultant, 400,000 option shares to consultants, 200,000 common shares for a waiver, and 750,000 restricted shares to consultants, all in reliance on Section 4(a)(2) and Rule 506 exemptions.
View raw filing on EDGAR →The Company granted equity options totaling 1,750,000 shares under the 2026 Equity Plan to named officers (Luisa Ingargiola, Meng Li, Sam Knipper) and non-employee directors as compensation for services rendered.
View raw filing on EDGAR →The Company filed a Certificate of Designation for Series F Convertible Preferred Stock with Delaware on July 2, 2026, establishing 5,000 authorized shares with 400 issued, creating new senior equity securities with conversion rights, mandatory redemption, and liquidation preferences that materially affect shareholder rights and capital structure.
View raw filing on EDGAR →The Board appointed Joanna Lohkamp as an interim director, Audit Committee member, and Remuneration Committee chair, effective July 1, 2026. This is a clear executive/board appointment that would materially affect investor assessment of the company's governance and leadership structure, particularly given her committee roles overseeing audit and compensation matters.
View raw filing on EDGAR →Alarum Technologies discloses that the FBI has seized domains associated with its subsidiary NetNut Ltd. in connection with residential proxy network operations. This is a material legal/regulatory event involving law enforcement action against the company's infrastructure. While the company states it will cooperate, the seizure itself represents a significant regulatory development that would affect a reasonable investor's assessment of legal and operational risk.
View raw filing on EDGAR →The 6-K discloses results of a June 18, 2026 special shareholder meeting where shareholders voted on approval of a debt financing transaction. The vote results are explicitly reported (6,076,941 for, 13,211 against, 930 abstentions out of 6,091,082 shares voted), which is the core content of the filing. While the filing also describes the debt financing itself, the primary disclosure is the shareholder vote outcome and its approval, making this a shareholder_vote_results event. The materiality is high because the approved financing ($3.5 million in convertible debt) is material to the company's capital structure.
View raw filing on EDGAR →FreeCast entered into a Securities Purchase Agreement on June 30, 2026, closing July 2, 2026, for a private placement of 4,666,667 shares of Class A common stock and pre-funded warrants to purchase 3,243,807 additional shares, raising approximately $23.7 million in gross proceeds. The securities were sold without registration under Section 4(a)(2) of the Securities Act and Regulation D to accredited investors. This is a classic dilutive equity issuance—unregistered private placement raising capital through equity dilution—disclosed under Item 1.01 (Material Definitive Agreement) and Item 3.02 (Unregistered Sale of Equity Securities).
View raw filing on EDGAR →The filing discloses completion of a previously announced acquisition of the SAXOPRINT and viaprinto businesses from CEWE Stiftung & Co. KGaA, with the acquired businesses being integrated into the Company's PrintBrothers segment. This is a material acquisition completion event that would affect investor assessment of the registrant's business scope and financial position.
View raw filing on EDGAR →The filing discloses both the resignation of Mark Pickering as CFO and Executive Officer (effective June 29, 2026) and the appointment of Carrie Rosorea as CFO and Executive Officer on the same date. While both events occur, the principal disclosed action is the appointment of a new CFO to fill the vacancy, making exec_appointment the primary classification. CFO changes are material to investors assessing management continuity and financial oversight.
View raw filing on EDGAR →This news release announces BTQ Technologies' receipt of final regulatory approval from French FDI authorities for its previously announced acquisition of QPerfect SAS, a French quantum computing company. The release discloses the completion of a material acquisition with a total purchase price of €18.6 million in closing consideration (cash and 2.2 million shares) plus earnout payments up to €5.7 million contingent on milestone achievement. The acquisition adds significant technology assets (MIMIQ quantum emulator, Digital Twin, and QLU control capabilities) and establishes BTQ's European R&D hub in Strasbourg, making this a material M&A event that would affect a reasonable investor's assessment of the company's strategic direction and financial position.
View raw filing on EDGAR →This news release announces the commercial launch of QuREKA, a hybrid quantum cloud platform operated by strategic partner SDT, powered by MIMIQ (BTQ's soon-to-be-acquired quantum emulator from QPerfect). The disclosure emphasizes this as "an important milestone for BTQ" and "a marquee milestone" in the context of the QPerfect acquisition strategy. While the event is operational in nature—a product launch and partnership milestone—it is material because it represents the first commercial deployment of a core technology BTQ is acquiring and establishes a revenue-generating channel in a key market (South Korea). The forward-looking statements and risk disclosures underscore the significance BTQ assigns to this launch and the underlying acquisition.
View raw filing on EDGAR →Sun Life announces completion of its acquisition of Bell Partners, a leading U.S. multifamily real estate investment manager, for US$350 million (approximately 80% paid in Sun Life common shares). This is a material acquisition that expands Sun Life's asset management capabilities and represents a significant strategic transaction requiring disclosure under Item 1.01 (Material Agreements) or Item 2.01 (Completion of Acquisition or Disposition).
View raw filing on EDGAR →Nexa Resources confirms awareness of ongoing negotiations between Votorantim S.A. (VSA) and Boliden AB regarding VSA's interest in the Company, and expects discussions with Boliden regarding "a potential transaction impacting the Company." This disclosure of active M&A negotiations—even at an early stage with no certainty of completion—is a material event that would affect a reasonable investor's assessment of the registrant's future ownership and control.
View raw filing on EDGAR →This 6-K furnishes a press release disclosing Embraer's second-quarter 2026 aircraft delivery results: 65 aircraft delivered (up 48% qoq and 7% yoy), with detailed segment breakdowns and updated full-year 2026 guidance. The disclosure of quarterly operational and financial metrics tied to revenue-generating deliveries is a material earnings-related announcement typical of an earnings release, even though it focuses on unit deliveries rather than GAAP net income.
View raw filing on EDGAR →The 6-K body announces a public offering of the 10th issue of simple debentures (unsecured bonds) by AXIA Energia S.A. for an initial amount of R$1,600,000,000 (approximately $320 million USD), with an additional lot option of up to R$400,000,000. This is a material debt issuance under the automatic registration procedure for professional investors, with an issue date of July 15, 2026, coordinated by major Brazilian financial institutions (Itaú BBA, Santander, Bradesco BBI, and UBS BB).
View raw filing on EDGAR →